GENE ONLINE|News &
Opinion
Blog

2026-02-03|

Organic Di-Selenide Hydrogel Microspheres Developed for Multimodal Osteoarthritis Treatment

by GOAI
Share To

Researchers have developed organic di-selenide hydrogel microspheres designed for the multimodal treatment of osteoarthritis, according to a recent study published in *Nature Communications*. The study outlines the creation and application of these microspheres, which aim to address the complex challenges associated with treating osteoarthritis through a combination of therapeutic approaches.

The research highlights that the hydrogel microspheres are composed of organic di-selenide bonds, which exhibit antioxidant properties and responsiveness to oxidative stress. These characteristics allow the microspheres to target inflammation and oxidative damage commonly observed in osteoarthritis. Additionally, the study demonstrates that these materials can deliver drugs locally while also providing mechanical support to damaged cartilage tissue. Researchers tested the efficacy of these microspheres in preclinical models, observing improvements in joint function and reductions in inflammatory markers. The findings suggest potential applications for this technology in managing osteoarthritis symptoms through a multifaceted approach.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies
2026-02-10
CCHH Receives Nasdaq Notice for Falling Below $1.00 Minimum Bid Price
2026-02-10
South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology
2026-02-10
Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men
2026-02-10
Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs
2026-02-10
Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion
2026-02-10
FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires
2026-02-09
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top